Skip to main content
Erschienen in: Metabolic Brain Disease 5/2017

17.06.2017 | Original Article

Clinical and molecular genetic features of cerebrotendinous xanthomatosis patients in Chinese families

verfasst von: Chen Chen, Yue Zhang, Hui Wu, Yi-Min Sun, Ye-Hua Cai, Jian-Jun Wu, Jian Wang, Ling-Yun Gong, Zheng-Tong Ding

Erschienen in: Metabolic Brain Disease | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Cerebrotendinous xanthomatosis (CTX) is a lipid-storage disease caused by mutations in CYP27A1. Current publications of Chinese CTX were mainly based on case reports. Here we investigated the clinical manifestations, genetic features in Chinese CTX patients. The clinical materials of 4 Chinese CTX pedigrees were collected. The genetic testing was done by polymerase chain reaction plus Sanger sequencing. The features of Chinese CTX patients reported previously were also reviewed. Three novel mutations of p.Arg513Cys, c.1477-2A > C in family 1 and p.Arg188Stop in family 4 (NM 000784.3) in CYP27A1 were found. The probands in our study manifested cerebellar ataxia, tendon xanthoma and spastic paresis in family 1 and 4, tendon xanthoma plus spastic paraparesis in family 2, asymptomatic tendon xanthoma in family 3. Three known mutations of p.Arg137Gln, p.Arg127Trp and p.Arg405Gln were found respectively in Family 2, 3 and 4. For the Chinese patients reviewed, the most common findings were xanthomatosis (100%), pyramidal signs (100%), cerebellar ataxia (66.7%), cognitive impairment (66.7%), cataracts (50.0%), and peripheral neuropathy (33.3%). Chronic diarrhea was infrequently seen (5.6%). No mutation was found associated with any given clinical features. We identified 3 novel mutations in CYP27A1. In Chinese CTX patients, xanthomatosis was the most common symptom while cataracts and chronic diarrhea were less frequent. The special features in Chinese CTX patients might caused by the lack of serum cholestanol test and should be confirmed in larger number of patients in the future.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Chang WN, Kuriyama M, Lui CC, Jeng SF, Chen WJ, Chee EC (1992) Cerebrotendinous xanthomatosis in three siblings from a Taiwanese family. J Formos Med Assoc 91:1190–1194PubMed Chang WN, Kuriyama M, Lui CC, Jeng SF, Chen WJ, Chee EC (1992) Cerebrotendinous xanthomatosis in three siblings from a Taiwanese family. J Formos Med Assoc 91:1190–1194PubMed
Zurück zum Zitat Di Taranto MD et al (2016) Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports. Metab Brain Dis. doi:10.1007/s11011-016-9841-y Di Taranto MD et al (2016) Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports. Metab Brain Dis. doi:10.​1007/​s11011-016-9841-y
Zurück zum Zitat Federico A, Dotti MT (2003) Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy. J Child Neurol 18:633–638CrossRefPubMed Federico A, Dotti MT (2003) Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy. J Child Neurol 18:633–638CrossRefPubMed
Zurück zum Zitat Garuti R, Lelli N, Barozzini M, Dotti MT, Federico A, Bertolini S, Calandra S (1996) Partial deletion of the gene encoding sterol 27-hydroxylase in a subject with cerebrotendinous xanthomatosis. J Lipid Res 37:662–672PubMed Garuti R, Lelli N, Barozzini M, Dotti MT, Federico A, Bertolini S, Calandra S (1996) Partial deletion of the gene encoding sterol 27-hydroxylase in a subject with cerebrotendinous xanthomatosis. J Lipid Res 37:662–672PubMed
Zurück zum Zitat Ko KF, Lee KW (2001) Cerebrotendinous xanthomatosis in three siblings from a Chinese family. Singapore Med J 42:30–32PubMed Ko KF, Lee KW (2001) Cerebrotendinous xanthomatosis in three siblings from a Chinese family. Singapore Med J 42:30–32PubMed
Zurück zum Zitat Koyama S, Kawanami T, Tanji H, Arawaka S, Wada M, Saito N, Kato T (2012) A case of cerebrotendinous xanthomatosis presenting with epilepsy as an initial symptom with a novel V413D mutation in the CYP27A1 gene. Clin Neurol Neurosurg 114:1021–1023. doi:10.1016/j.clineuro.2012.01.032 CrossRefPubMed Koyama S, Kawanami T, Tanji H, Arawaka S, Wada M, Saito N, Kato T (2012) A case of cerebrotendinous xanthomatosis presenting with epilepsy as an initial symptom with a novel V413D mutation in the CYP27A1 gene. Clin Neurol Neurosurg 114:1021–1023. doi:10.​1016/​j.​clineuro.​2012.​01.​032 CrossRefPubMed
Zurück zum Zitat Lee MH et al (2001) Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees. J Lipid Res 42:159–169PubMedPubMedCentral Lee MH et al (2001) Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees. J Lipid Res 42:159–169PubMedPubMedCentral
Zurück zum Zitat Lee MJ, Huang YC, Sweeney MG, Wood NW, Reilly MM, Yip PK (2002) Mutation of the sterol 27-hydroxylase gene ( CYP27A1) in a Taiwanese family with cerebrotendinous xanthomatosis. J Neurol 249:1311–1312. doi:10.1007/s00415-002-0762-9 CrossRefPubMed Lee MJ, Huang YC, Sweeney MG, Wood NW, Reilly MM, Yip PK (2002) Mutation of the sterol 27-hydroxylase gene ( CYP27A1) in a Taiwanese family with cerebrotendinous xanthomatosis. J Neurol 249:1311–1312. doi:10.​1007/​s00415-002-0762-9 CrossRefPubMed
Zurück zum Zitat Mak CM, Lam KS, Tan KC, Ma OC, Tam S (2004) Cerebrotendinous xanthomatosis in a Hong Kong Chinese kinship with a novel splicing site mutation IVS6-1G>T in the sterol 27-hydroxylase gene. Mol Genet Metab 81:144–146CrossRefPubMed Mak CM, Lam KS, Tan KC, Ma OC, Tam S (2004) Cerebrotendinous xanthomatosis in a Hong Kong Chinese kinship with a novel splicing site mutation IVS6-1G>T in the sterol 27-hydroxylase gene. Mol Genet Metab 81:144–146CrossRefPubMed
Zurück zum Zitat Nie S, Chen G, Cao X, Zhang Y (2014) Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management Orphanet journal of rare diseases 9:179 doi:10.1186/s13023-014-0179-4 Nie S, Chen G, Cao X, Zhang Y (2014) Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management Orphanet journal of rare diseases 9:179 doi:10.​1186/​s13023-014-0179-4
Zurück zum Zitat Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424. doi:10.1038/gim.2015.30 CrossRefPubMedPubMedCentral Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424. doi:10.​1038/​gim.​2015.​30 CrossRefPubMedPubMedCentral
Zurück zum Zitat Rubio-Agusti I, Kojovic M, Edwards MJ, Murphy E, Chandrashekar HS, Lachmann RH, Bhatia KP (2012) Atypical parkinsonism and cerebrotendinous xanthomatosis report of a family with corticobasal syndrome and a literature review. Mov Disord 27:1769–1774. doi:10.1002/mds.25229 CrossRefPubMed Rubio-Agusti I, Kojovic M, Edwards MJ, Murphy E, Chandrashekar HS, Lachmann RH, Bhatia KP (2012) Atypical parkinsonism and cerebrotendinous xanthomatosis report of a family with corticobasal syndrome and a literature review. Mov Disord 27:1769–1774. doi:10.​1002/​mds.​25229 CrossRefPubMed
Zurück zum Zitat Schimschock JR, Alvord EC Jr, Swanson PD (1968) Cerebrotendinous xanthomatosis. Clinical and pathological studies Archives of neurology 18:688–698CrossRefPubMed Schimschock JR, Alvord EC Jr, Swanson PD (1968) Cerebrotendinous xanthomatosis. Clinical and pathological studies Archives of neurology 18:688–698CrossRefPubMed
Zurück zum Zitat Verrips A et al (1999) Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain 122(Pt 8):1589–1595CrossRefPubMed Verrips A et al (1999) Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain 122(Pt 8):1589–1595CrossRefPubMed
Zurück zum Zitat Verrips A et al (2000) Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 123(Pt 5):908–919CrossRefPubMed Verrips A et al (2000) Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 123(Pt 5):908–919CrossRefPubMed
Zurück zum Zitat Wang PW, Chang WN, Lu CH, Chao D, Schrag C, Pan TL (2006) New insights into the pathological mechanisms of cerebrotendinous xanthomatosis in the Taiwanese using genomic and proteomic tools. Proteomics 6:1029–1037. doi:10.1002/pmic.200500159 CrossRefPubMed Wang PW, Chang WN, Lu CH, Chao D, Schrag C, Pan TL (2006) New insights into the pathological mechanisms of cerebrotendinous xanthomatosis in the Taiwanese using genomic and proteomic tools. Proteomics 6:1029–1037. doi:10.​1002/​pmic.​200500159 CrossRefPubMed
Zurück zum Zitat Wang Z, Yuan Y, Zhang W, Zhang Y, Feng L (2007) Cerebrotendinous xanthomatosis with a compound heterozygote mutation and severe polyneuropathy. Neuropathology 27:62–66CrossRefPubMed Wang Z, Yuan Y, Zhang W, Zhang Y, Feng L (2007) Cerebrotendinous xanthomatosis with a compound heterozygote mutation and severe polyneuropathy. Neuropathology 27:62–66CrossRefPubMed
Zurück zum Zitat Wu ZY et al (2006) Mutation analysis of 218 Chinese patients with Wilson disease revealed no correlation between the canine copper toxicosis gene MURR1 and Wilson disease. J Mol Med (Berlin, Germany) 84:438–442. doi:10.1007/s00109-005-0036-y CrossRef Wu ZY et al (2006) Mutation analysis of 218 Chinese patients with Wilson disease revealed no correlation between the canine copper toxicosis gene MURR1 and Wilson disease. J Mol Med (Berlin, Germany) 84:438–442. doi:10.​1007/​s00109-005-0036-y CrossRef
Metadaten
Titel
Clinical and molecular genetic features of cerebrotendinous xanthomatosis patients in Chinese families
verfasst von
Chen Chen
Yue Zhang
Hui Wu
Yi-Min Sun
Ye-Hua Cai
Jian-Jun Wu
Jian Wang
Ling-Yun Gong
Zheng-Tong Ding
Publikationsdatum
17.06.2017
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 5/2017
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-017-0047-8

Weitere Artikel der Ausgabe 5/2017

Metabolic Brain Disease 5/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.